VEDAN INT'L(02317) released its annual performance results, with a net profit attributable to shareholders of $17.056 million, representing a year-on-year increase of 6.29%.

VEDAN INT'L (02317) announced its annual performance for the year ending December 31, 2025, with revenue of 375 million US dollars, a decrease of 1.43% compared to the previous year; net profit attributable to shareholders was 17.056 million US dollars, an increase of 6.29% compared to the previous year; earnings per share were 1.12 US cents; and a final dividend of 0.82 US cents. The announcement stated that the decrease in revenue was mainly due to the sluggish market conditions and slowing demand in various markets. Among the group's main products, sales prices and revenue of monosodium glutamate products have decreased due to slowing consumer market demand and increased competition, but lower raw material and energy costs compared to last year have helped to maintain gross profit margin compared to the previous year; modified starch has maintained its market price despite oversupply in Thailand, resulting in a slight increase in gross profit compared to the previous period despite a decrease in sales volume; demand for specialized products remains weak due to the sluggish economy and competitive pressure, resulting in a slight decrease in sales and revenue compared to the previous period. Hydrochloric acid has also seen a decrease in revenue compared to last year due to weak market demand, despite slightly lower raw material and energy costs, leading to a slight increase in gross profit compared to last year; animal feed products are actively developing other product lines to address market competition and low demand. In addition, revenue from other products of the group, such as coffee and bulk ingredients, has increased compared to last year due to price increases and growing demand.